Kyverna Therapeutics Congratulates the Teams at the Universities of Bochum and Magdeburg for a Late Breaker Case Report in a Patient with Refractory Myasthenia Gravis Treated with Investigational KYV-101 ...Middle East

The severely disabled and treatment-refractory patient was discharged without symptoms three weeks after KYV-101 infusion and was fully mobile 60 days after, with no observed adverse events related to CAR T-cell therapy The late breaker abstract was presented on November 11, 2023 at the...

Hence then, the article about kyverna therapeutics congratulates the teams at the universities of bochum and magdeburg for a late breaker case report in a patient with refractory myasthenia gravis treated with investigational kyv 101 was published today ( Saturday 11/11/2023 - 05:00 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Kyverna Therapeutics Congratulates the Teams at the Universities of Bochum and Magdeburg for a Late Breaker Case Report in a Patient with Refractory Myasthenia Gravis Treated with Investigational KYV-101 )

Also on site :

• Art Garfunkel Makes Surprise Return to Madison Square Garden with Charlie Puth in Special Performance of "The Boxer"
• EU and NATO pushing Romania toward war with Russia – MEP
• Today’s Wordle Hint, Answers for 1806 on Saturday, May 30, 2026